Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Priveterra Acquisition Corp II (NQ: PMGM )

11.09 UNCHANGED
Last Price Updated: 2:53 PM EDT, May 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 11.09
Bid (Size) 11.05 (11)
Ask (Size) 11.23 (4)
Prev. Close 11.09
Today's Range 11.09 - 11.09
52wk Range 6.810 - 14.68
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Priveterra Acquisition Corp. II Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
From Priveterra Acquisition Corp. II
Via Business Wire
What's Going On With Priveterra, AEON Biopharma Shares Today?
Priveterra Acquisition Corp (NASDAQ: PMGM) on Monday announced the closing of its business combination with AEON Biopharma. 
Via Benzinga

Performance

YTD
+0.73%
+0.73%
1 Month
-1.07%
-1.07%
3 Month
+0.82%
+0.82%
6 Month
+2.31%
+2.31%
1 Year
+7.98%
+7.98%

More News

Read More
Priveterra Acquisition Corp. Announces Completion of Business Combination with AEON Biopharma, Inc.
From Priveterra Acquisition Corp.
Via Business Wire
Why Metropolitan Bank Holding Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Dow Rises 50 Points; American Express Earnings Top Views
Via Benzinga
Priveterra Acquisition Corp. Announces Authorization to List on NYSE Upon Completion of Business Combination with AEON Biopharma, Inc.
From Priveterra Acquisition Corp.
Via Business Wire
Priveterra Acquisition Corp. Announces Intention to Transfer to NYSE Upon Completion of Business Combination with AEON Biopharma, Inc.
From Priveterra Acquisition Corp.
Via Business Wire
Why Lucid Group Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
AEON Biopharma and Priveterra Acquisition Corp. Announce Filing of S-4 Registration Statement for Proposed Business Combination
From Priveterra Acquisition Corp. and AEON Biopharma, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.